[e-drug] Essential Medicines & Pharmaceutical Policies: Biennial Report

E-DRUG: Essential Medicines & Pharmaceutical Policies: Biennial Report
---------------------------------------------------------------------

E-drug received this message from WHO/EMP:

--
The past two years have been busy for the Essential Medicines and
Pharmaceutical Policies Department at WHO.

KEY ACHIEVEMENTS IN 2008–2009
• Over 90 countries were supported by EMP in 2008–2009, with over 80
countries and sub-regions receiving technical support to develop,
implement and monitor national medicine policies.
• The WHO/UN Medicines Prequalification Programme prequalified 84
medicines, including 14 paediatric formulations and medicines for H1N1
influenza and reproductive health.
• Global indicators for access to essential medicines were established.
• The 13th International Conference of Drug Regulatory Authorities
(ICDRA) brought together over 300 representatives from 96 countries.
• The Essential Medicines Monitor was relaunched as an electronic
newsletter on the web.
• Quarterly assessment and reporting of the impact of the financial
crisis on access to essential medicines were initiated.

Please take a moment to look through our 2008-2009 Biennial Report
available on our website:
http://apps.who.int/medicinedocs/documents/s16822e/s16822e.pdf

Liz Finney
Communications, Advocacy and Resource Mobilization Officer
Department of Essential Medicines and Pharmaceutical Policies
World Health Organization
Geneva, Switzerland
Tel +41 22 791.1866
www.who.int/medicines/en/index.html
finneye@who.int